BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Bristol Myers Squibb Receives U.S. FDA Approval of New State-of-the-Art Cell Therapy Manufacturing Facility

Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved commercial production at the compa...

June 09, 2023 | News

Merck Announces Proteologix as Winner of its North American Advance Biotech Grant

Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from Me...

June 07, 2023 | News

Samsung Biologics Hastens Timeline for New Plant, Aiming for April 2025 Launch

Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant- Key features of Plant ...

June 07, 2023 | News

Immorna Initiates Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine

"The initiation of our FIH study with JCXH-105 is an important milestone for Immorna and for the development of a potential innovative vaccine for Shingles...

May 31, 2023 | News

Amplo Biotech Secures Fast Track Funding for Promising Gene Therapy Targeting Collagen Q Deficiency

Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...

May 30, 2023 | News

Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix® Blood Test to Detect Prostate Cancer

Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced today that it entered into an agreement for Labcorp, a...

May 22, 2023 | News

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Along with these additions to the site leadership team, the company has also appointed Erik Riley as Senior Vice President, Corporate Planning. T...

May 19, 2023 | News

Antengene Clears U.S. IND for Phase I Trial of ATG-031 Antibody

- ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncolog...

May 18, 2023 | News

Neutec Group Launches oCelloscope: Automated Microbial Live-Cell Imaging by Biosense Solutions

With +80 US/EU peer reviewed publications, the oCelloScope is a one-of-a-kind workhorse in many microbial applications. In AST,...

May 17, 2023 | News

Thermo Fisher Scientific Expands ImmunoCAP™ Test Availability Across U.S.

Thermo Fisher Scientific, the world leader in serving science, today announced it is making ImmunoCAP™ Specific IgE tests available to more patients ...

May 11, 2023 | News

Eppendorf Group inaugurates new Distribution Center in the USA

New distribution center officially opened in Enfield, Connecticut Targeted strengthening of the supply chain and of the customer focus throughout the Am...

May 11, 2023 | News

Biosion shares Anti-CD40 Agonistic Antibody discovery and development data at PEGS

BSI-038 is an anti-CD40 agonistic monoclonal antibody, discovered through Biosion's H³ antibody discovery platform. BSI-038 exhibits enhanced bin...

May 09, 2023 | News

Clinisys Acquires Promium to Further Grow Scientific, Environmental and Public Health Diagnostics Capabilities

Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated...

May 04, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

May 02, 2023 | News

Stay Connected